Flexion Therapeutics (FLXN) Stock Analyst Earnings Estimates
NASDAQ:FLXN - Nasdaq -
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.52M 6,155.56% | 72.96M 223.98% | 85.55M 17.26% | 110.157M 28.76% | 161.311M 46.44% | 214.875M 33.21% | 294.549M 37.08% | 411.841M 39.82% | |
| EBITDA YoY % growth | -157.49M -23.36% | -135.21M 14.15% | -91.32M 32.46% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -159.2M -22.76% | -136.27M 14.40% | -93.02M 31.74% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -706.93% | -186.77% | -108.73% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -4.48 -7.69% | -3.93 12.28% | -2.61 33.59% | -2.11 18.99% | -1.41 33.09% | -0.72 48.89% | -1.00 -38.23% | -1.41 -40.99% |
| Q4 / 21 | Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.48 -20.95% | -0.50 13.03% | -0.42 4.49% | -0.42 27.88% | -0.39 19.88% |
| Revenue Q2Q % growth | 31.624M 20.20% | 31.068M 26.34% | 35.102M 24.58% | 36.364M 70.51% | 39.762M 25.73% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -15.26% | -0.58 | % | |
| Q2 2021 Q2Q % growth | -0.44 42.11% | -0.51 | 0.07 | 13.93% |
| Q1 2021 Q2Q % growth | -0.57 40.00% | -0.53 | -0.04 | -7.33% |
| Q4 2020 Q2Q % growth | -0.40 54.55% | -0.45 | 0.05 | 10.91% |
| Q3 2020 Q2Q % growth | -0.50 50.00% | -0.52 | 0.02 | 4.68% |
| Q2 2020 Q2Q % growth | -0.76 20.83% | -0.67 | -0.09 | -13.87% |
| Q1 2020 Q2Q % growth | -0.95 12.84% | -1.02 | 0.07 | 6.55% |
| Q4 2019 Q2Q % growth | -0.88 | -0.97 | 0.09 | 9.40% |
| Q3 2019 Q2Q % growth | -1.00 | -0.98 | -0.02 | -1.87% |
| Q2 2019 Q2Q % growth | -0.96 | -1.07 | 0.11 | 9.98% |
| Q1 2019 Q2Q % growth | -1.09 | -1.10 | 0.01 | 1.26% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 21.326M -9.86% | 24.77M | -3.444M | -13.90% |
| Q2 2021 Q2Q % growth | 28.175M 82.36% | 29.588M | -1.413M | -4.78% |
| Q1 2021 Q2Q % growth | 24.59M 22.16% | 25.269M | -678.797K | -2.69% |
| Q4 2020 Q2Q % growth | 26.31M 11.25% | 26.912M | -601.507K | -2.24% |
| Q3 2020 Q2Q % growth | 23.66M 8.58% | 23.951M | -290.875K | -1.21% |
| Q2 2020 Q2Q % growth | 15.45M -8.85% | 16.663M | -1.213M | -7.28% |
| Q1 2020 Q2Q % growth | 20.13M 90.63% | 19.857M | 272.64K | 1.37% |
| Q4 2019 Q2Q % growth | 23.65M | 24.027M | -376.671K | -1.57% |
| Q3 2019 Q2Q % growth | 21.79M | 19.393M | 2.397M | 12.36% |
| Q2 2019 Q2Q % growth | 16.95M | 14.993M | 1.957M | 13.06% |
| Q1 2019 Q2Q % growth | 10.56M | 11.211M | -650.82K | -5.81% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |